Search Results - "Heylen, S L"

Pilot clinical investigation of risperidone in the treatment of psychotic patients by Gelders, Y G, Heylen, S L, Vanden Bussche, G, Reyntjens, A J, Janssen, P A

“…Sixty-one adult psychotic patients were treated for four weeks in an open dose-finding study with the new combined serotonin-dopamine antagonist risperidone (R…”
Get more information

Risperidone, a new antipsychotic with serotonin 5-HT2 and dopamine D2 antagonistic properties by Heylen, S L, Gelders, Y G

Get more information

The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study by Castelão, J F, Ferreira, L, Gelders, Y G, Heylen, S L

“…After a wash-out period of 1 week, 20 patients suffering from schizophrenia were treated for 4 weeks in an open dose-finding study with a new…”
Get more information

Placebo response in schizophrenia. Discussion by LEWANDER, T, HEYLEN, S. L. E

Get full text

Development of new antipsychotic drugs by Vanden Bussche, G, Gelders, Y G, Heylen, S L

“…As far as schizophrenia is concerned, therapeutical effects of neuroleptics based on brain-located dopamine receptor blockers are taken for granted. It is also…”
Get more information